Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments.
Explore this paper's citation graph
Summary
The results suggest that the phosphorylation of each site in tau differs among the maturing stages of neurofibrillary change and that abnormal phosphorylated tau in the neuronal soma occurs at 199, 202, 409 and 422 earlier than at threonine 231 and serine 396.
- Type
- article
- Published
- 1996-07-01
- Cited by
- 146
- References
- 0
- OpenAlex
- https://openalex.org/W1975596414
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20658993
Keywords
Phosphorylation, Threonine, Serine, Tau protein, Immunostaining
References
No references recorded for this paper.
Cited by
- Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.
- Pathways of tau fibrillization.
- Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
- Short-Term High-Fat-and-Fructose Feeding Produces Insulin Signaling Alterations Accompanied by Neurite and Synaptic Reduction and Astroglial Activation in the Rat Hippocampus
- Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus
- IMMUNOTHERAPY IN COMBINATION WITH BEHAVIORAL ENRICHMENT IN A CANINE MODEL OF AGING
- ASYN and tau interaction : new drug target for neurodegenerative diseases
- Modulation of Histone Deacetylases Attenuates the Pathogenesis of Alzheimer's disease
- Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer’s cortical synapses
- Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.
- L-3-n-butylphthalide Reduces Tau Phosphorylation and Improves Cognitive Deficits in AβPP/PS1-Alzheimer's Transgenic Mice
- Glucocorticoids trigger Alzheimer disease‐like pathobiochemistry in rat neuronal cells expressing human tau
- Interaction between p85 and Rab5 in the presences and absence of phosphorylated PDGFR peptide
- Tau aggregation and toxicity in tauopathic neurodegenerative diseases
- Earliest Stages of Tau Conformational Changes are Related to the Appearance of a Sequence of Specific Phospho-Dependent Tau Epitopes in Alzheimer's Disease
- Tau Protein in Normal and Alzheimer's Disease Brain: An Update
- Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease
- Stress Acts Cumulatively To Precipitate Alzheimer's Disease-Like Tau Pathology and Cognitive Deficits
- Hyperphosphorylation of tau by GSK-3β in Alzheimer’s disease: The interaction of Aβ and sphingolipid mediators as a therapeutic target
- Yeast as a Model System to Study Tau Biology
Related papers
- The destruction of serine and threonine during acid hydrolysis.
- A study on L-threonine and L-serine uptake in Escherichia coli K-12
- Synthesis of phosphopeptides: A simple phosphorylation procedure for serine and threonine
- Amino acid distributions around O-linked glycosylation sites.
- OGlcNAcylation and Phosphorylation Have Similar Structural Effects in α-Helices: Post-Translational Modifications as Inducible Start and Stop Signals in α-Helices, with Greater Structural Effects on Threonine Modification
- EVIDENCE FOR STRICTLY Na+‐DEPENDENT ACCUMULATION OF SERINE AND THREONINE IN BRAIN CORTICAL SYNAPTOSOMES FROM NEWBORN RATS
- Synthesis of human growth hormone-releasing hormone via three-fragment serine/threonine ligation (STL).
- Insulin-stimulated serine and threonine phosphorylation of the human insulin receptor. An assessment of the role of serines 1305/1306 and threonine 1348 by their replacement with neutral or negatively charged amino acids.
- Influence of sequence on the fragmentation of serine- and threonine-containing peptides in 252Cf-plasma desorption mass spectrometry.